| 期刊論文| 1. | Newhouse, Joseph P.(1970)。Toward a Theory of Nonprofit Institutions: An Economic Model of a Hospital。American Economic Review，60(1)，64-74。   | | 2. | 蘇麗華(1998)。藥價黑洞深不可測。卓越雜誌，11，76-79。 延伸查詢 | | 3. | 劉士永(2004)。醫療、疾病與臺灣社會的近代性格。歷史月刊，201，92-100。 延伸查詢 | | 4. | 盧瑞芬、謝啟瑞(20030300)。臺灣醫院產業的市場結構與發展趨勢分析。經濟論文叢刊，31(1)，107-153。 延伸查詢 | | 5. | 程馨、謝啟瑞(20050100)。全民健保藥品政策與藥品費用的經濟分析。經社法制論叢，35，1-42。 延伸查詢 | | 6. | Grossman, Michael(1972)。On the Concept of Health Capital and the Demand for Health。Journal of Political Economy，80(2)，223-255。 | | 7. | Reinhardt, Uwe(2004)。An Informational Infrastructure for the Pharmaceutical Market。Health Affairs，23(1)，107-112。 | | 8. | Grabowski, Henry G.、Vernon, John M.(1992)。Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act。The Journal of Law & Economics，35(2)，331-350。 | | 9. | Chou, Y. J.、Yip, Winnie C.、Lee, Cheng-Hua、黃心苑、Sun, Ying-Pei、張鴻仁(2003)。Impact of Separating Drug Prescribing and Dispensing on Provider Behaviour: Taiwan's Experience。Health Policy and Planning，18(3)，316-329。 | | 10. | Berndt, Ernst R.、Bui, Linda、Reiley, David R.、Urban, Glen L.(1995)。Information, Marketing, and Pricing in the U. S. Antiulcer Drug Market。The American Economic Review，85(2)，100-105。 | | 11. | Anderson, Gerard F.、Reinhardt, Uwe E.、Hussey, Peter S.、Petrosyan, Varduhi(2003)。It's the Price, Stupid: Why the United States Is So Different from Other Countries。Health Affairs，22(3)，89-105。 | | 12. | Caves, Richard E.、Whinston, Michael D.、Hurwitz, Mark A.(1991)。Patent Expiration, Entry, and Competition in the U. S. Pharmaceutical Industry。Brookings Papers on Economic Activity, Microeconomics，1-48。 | | 13. | Epstein, Arnold M.、Lee, Thomas H.、Hamel, Mary Beth(2004)。Paying Physicians for High-quality Care。The New England Journal of Medicine，350(4)，406-410。 | | 14. | Reinhardt, Uwe(2001)。Perspectives on the Pharmaceutical Industry。Health Affairs，20(5)，136-149。 | | 15. | Ekelund, Mats、Persson, Bjorn(2003)。Pharmaceutical Pricing in a Regulated Market。The Review of Economics and Statistics，85(2)，298-306。 | | 16. | O'Brien, Bernie(1989)。The Effect of Patient Charges on the Utilisation of Prescription Medicines。Journal of Health Economics，8(1)，109-132。 | | 17. | DiMasi, Joseph A.、Hansen, Ronald W.、Grabowski, Henry G.(2003)。The Price of Innovation: New Estimates of Drug Development Costs。Journal of Health Economics，22(2)，151-185。 | | 18. | Arrow, Kenneth J.(1963)。Uncertainty and Welfare Economics of Medical Care。The American Economic Review，53(3)，941-973。 | 會議論文| 1. | Reinhardt, Uwe(2005)。Paying the Providers of Health Care: Rewarding Superior Quality。0。 | 圖書| 1. | Santerre, Rexford E.、Neun, Stephen P.(1996)。Health Economics: Theories, Insights, and Industry Studies。Health Economics: Theories, Insights, and Industry Studies。Burr Ridge, IL：Irwin。 | | 2. | National Economic Research Associates(2002)。Taiwan Pharmaceutical Price Gap。Taiwan Pharmaceutical Price Gap。London, UK。 | | 3. | 葉金川(2003)。全民健保傳奇，第二冊。全民健保傳奇，第二冊。臺北。 延伸查詢 | | 4. | Patented Medicine Prices Review Board(2003)。PMPRB Annual Report。PMPRB Annual Report。Canada。 | | 5. | Scherer, F. M.(2000)。The Pharmaceutical Industry。Handbook of Health Economics, Vol. 1B。Amsterdam, Netherlands。 | | 6. | McGuire, Thomas G.(2000)。Physician Agency。Handbook of Health Economics, Vol. 1A。Amsterdam, Netherlands。 | |